Non-Invasive Advanced Genomic Testing for Embryo Health
BHALESHA is developing non-invasive genomic analysis to support IVF clinics and families navigating PGT-A, PGT-M, and PGT-SR.
Non-Invasive PGT Analysis Areas
Our platform is designed to support PGT-A, PGT-M, and PGT-SR through non-invasive genomic analysis, with testing and clinical interpretation directed by qualified professionals.
Assess embryo data for whole-chromosome gains and losses that may affect embryo selection.
Support targeted analysis for a specific disease-causing variant identified in a family.
Assess embryo data for chromosome imbalances associated with a known parental translocation, inversion, or other structural rearrangement.
Our planned family package
Family 6. Built around your embryos.
Genetic data from both parents. Screening of up to six embryos using embryo culture fluid. One coordinated process through your IVF clinic.
Your clinic will collect blood from both genetic parents and culture fluid from each embryo. The laboratory will prepare the genetic data, review the embryo results, and report to your IVF doctor.
Access and download available genomic files from your testing to keep or share with your doctor, subject to consent and laboratory release policies.
niPGT+ · Planned expansion
PGT-A, with more planned.
The planned niPGT+ package builds on PGT-A with PGT-SR, PGT-M, a Live Birth Score, and a Couple's Risk Report.
Starting point
PGT-A
Analysis for whole-chromosome gains and losses.
Planned addition
PGT-SR
Analysis for chromosome imbalances linked to a known parental rearrangement.
Planned addition
PGT-M
Targeted analysis for a known inherited condition in the family.
Planned addition
Live Birth Score
A proposed live-birth likelihood estimate for review with your IVF clinic.
Each feature requires validation and a defined scope before clinical use. A Live Birth Score would be an estimate and cannot guarantee pregnancy or live birth.
Couple's Risk Report · Coming with niPGT+
Understand inherited risks together.
Could we pass an inherited condition to our child?
A couple's risk report is planned as part of niPGT+. The laboratory would review findings from both genetic parents for inherited conditions relevant to family planning and targeted embryo testing. Your clinic would explain the findings and next steps.
This planned report is subject to laboratory validation and a defined testing scope. A couple's report does not establish whether an individual embryo is affected.
How It Will Work
We are building this service for IVF clinics. Here is the planned process.
Your Clinic Starts
Your IVF clinic will order the test and collect the needed samples.
The Lab Prepares the Data
A partner lab will prepare the samples and send the genetic data to Bhalesha through a secure system.
The Lab Checks Results
Bhalesha's software will help study the data. The lab will check the results and send a report to your IVF doctor.
Your Clinic Explains
Your IVF clinic will explain the results and next steps. It will arrange genetic counseling through its own team or another provider.
About Bhalesha
Built around clinics, labs, and families.
BHALESHA is developing non-invasive genomic analysis to support IVF clinics and laboratory partners in understanding embryo health. Our work brings together PGT-A, PGT-M, and PGT-SR analysis with clinical interpretation directed by qualified professionals.
We welcome conversations with IVF clinics, laboratories, investors, and partners. Private platform demonstrations are arranged directly with our team.
Connect with BhaleshaReady to Transform Your Genetic Testing?
Explore clinic-directed, non-invasive genomic analysis for PGT-A, PGT-M, and PGT-SR